Replies to post #822 on ImmunoGen Inc (IMGN)

[skitahoe]

Estimates are all over the place, I believe $1 billion by 2024 is fair for now, but the big question is expansion into other cancers where substantial percentages are platinum resistant. If anecdotal evidence builds from off label use MIRV certainly could reach a few billion or more in a few years.

Gary